Effects of shallomin and podophyllin solution 25% for genital HPV warts in women: a randomized controlled trial

被引:5
作者
Shahali, Shadab [1 ]
Amin, Mansour [2 ,3 ]
Hassani, Masoumeh Khajeh [4 ]
Yaghoobi, Reza [5 ]
Saki, Morteza [3 ,6 ]
机构
[1] Tarbiat Modares Univ, Fac Med Sci, Dept Reprod Hlth & Midwifery, Tehran, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Infect & Trop Dis Res Ctr, Ahvaz, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Microbiol, Golestan St, Ahvaz, Iran
[4] Ahvaz Jundishapur Univ Med Sci, Reprod Hlth Promot Res Ctr, Dept Midwifery, Ahvaz, Iran
[5] Ahvaz Jundishapur Univ Med Sci, Dept Dermatol, Ahvaz, Iran
[6] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran
关键词
Podophyllin; Genital wart; Human papillomavirus; ALLIUM-HIRTIFOLIUM; PERSIAN SHALLOT;
D O I
10.4103/2221-6189.259111
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To compare the effect of shallomin (pure fraction of Allium hirtifolium) with podophyllin 25% solution on external genital human papillomavirus warts in women. Methods: This study was a randomized controlled trial which was performed on two groups of 25 Iranian women with external genital warts at Imam Khomeini Hospital in Ahvaz, Iran. In the first group, shallomin was used once a day for six weeks at home. In the second group, 25% podophyllin solution, was applied on the lesion once weekly for six weeks. Results: Shallomin and podophyllin resulted in wart clearance in 13/23 (56.5%), and 12/24 (50%) of patients, respectively. The clearance rate for shallomin was not significantly different from that of podophyllin (P=0.082). Six weeks after the treatment, the sizes of the lesions in the shallomin group and the podophyllin group decreased by (1.43 +/- 0.53) mm and (1.64 +/- 0.70) mm, respectively. Conclusion: Shallomin is an effective treatment for genital warts, with similar efficacy to that of podophyllin.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [41] A randomised controlled non-inferiority trial to compare the efficacy of 'HPV screen, triage and treat' with 'HPV screen and treat' approach for cervical cancer prevention among women living with HIV
    Joshi, Smita
    Muwonge, Richard
    Bhosale, Ramesh
    Chaudhari, Pritam
    Kulkarni, Vinay
    Mandolkar, Mahesh
    Deodhar, Kedar
    Kand, Seema
    Phadke, Nikhil
    Rajan, Shobini
    Kumar, B. Kishore
    Sankaranarayanan, Rengaswamy
    Basu, Partha
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [42] Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial
    Zhu, Feng-Cai
    Hu, Shang-Ying
    Hong, Ying
    Hu, Yue-Mei
    Zhang, Xun
    Zhang, Yi-Ju
    Pan, Qin-Jing
    Zhang, Wen-Hua
    Zhao, Fang-Hui
    Zhang, Cheng-Fu
    Yang, Xiaoping
    Yu, Jia-Xi
    Zhu, Jiahong
    Zhu, Yejiang
    Chen, Feng
    Zhang, Qian
    Wang, Hong
    Wang, Changrong
    Bi, Jun
    Xue, Shiyin
    Shen, Lingling
    Zhang, Yan-Shu
    He, Yunkun
    Tang, Haiwen
    Karkada, Naveen
    Suryakiran, Pemmaraju
    Bi, Dan
    Struyf, Frank
    CANCER MEDICINE, 2019, 8 (14): : 6195 - 6211
  • [43] Effectiveness of a Web-Based Tailored Intervention With Virtual Assistants Promoting the Acceptability of HPV Vaccination Among Mothers of Invited Girls: Randomized Controlled Trial
    Pot, Mirjam
    Paulussen, Theo G. W. M.
    Ruiter, Robert A. C.
    Eekhout, Iris
    de Melker, Hester E.
    Spoelstra, Maxine E. A.
    van Keulen, Hilde M.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2017, 19 (09)
  • [44] Primary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese population
    Chan, Karen K. L.
    Liu, Stephanie S.
    Wei, Na
    Ngu, Siew F.
    Chu, Mandy M. Y.
    Tse, Ka Y.
    Lau, Lesley S. K.
    Cheung, Annie N. Y.
    Ngan, Hextan Y. S.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (04) : 1152 - 1162
  • [45] Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years Interim Analysis of a Phase 2 Double-Blind, Randomized, Controlled Trial
    Konno, Ryo
    Tamura, Shinobu
    Dobbelaere, Kurt
    Yoshikawa, Hiroyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (03) : 404 - 410
  • [46] Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a US healthcare system: The STEP trial
    Winer, Rachel L.
    Lin, John
    Anderson, Melissa L.
    Tiro, Jasmin A.
    Meenan, Richard T.
    Hansen, Kristina
    Gao, Hongyuan
    Sparks, Angela
    Greene, Dina N.
    Kilgore-Martin, Sony
    Green, Beverly B.
    Buist, Diana S. M.
    CONTEMPORARY CLINICAL TRIALS, 2022, 122
  • [47] Impact of antiviral AV2 in the topical treatment of HPV-associated lesions of the cervix: Results of a phase III randomized placebo-controlled trial
    Mutombo, Alex Baleka
    Tozin, Rahma
    Kanyiki, Hollande
    Van Geertruyden, Jean-Pierre
    Jacquemyn, Yves
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 15
  • [48] Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial
    Firnhaber, Cynthia
    Swarts, Avril
    Goeieman, Bridgette
    Rakhombe, Ntombi
    Mulongo, Masangu
    Williamson, Anna-Lise
    Michelow, Pam
    Ramotshela, Sibongile
    Faesen, Mark
    Levin, Simon
    Wilkin, Timothy
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 76 (05) : 532 - 538
  • [49] Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a US healthcare system
    Winer, Rachel L.
    Tiro, Jasmin A.
    Miglioretti, Diana L.
    Thayer, Chris
    Beatty, Tara
    Lin, John
    Gao, Hongyuan
    Kimbel, Kilian
    Buist, Diana S. M.
    CONTEMPORARY CLINICAL TRIALS, 2018, 64 : 77 - 87
  • [50] Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial
    Magnan, S.
    Tota, J. E.
    El-Zein, M.
    Burchell, A. N.
    Schiller, J. T.
    Ferenczy, A.
    Tellier, P. -P.
    Coutlee, F.
    Franco, E. L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (02) : 210 - 216